Skip to main content Start main content

Preventing and treating Alzheimer’s disease via neuronal protection with drugs


Novel Multifunctional and Disease-modifying Dimers for Treating Alzheimer’s Disease

Mainly affecting the ageing population, Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by the impairment of cognitive functions such as memory, thinking and behaviors. Currently, the single targeted anti-AD drugs have low efficacy and can only improve the symptoms. Therefore, further research and development of more efficacious and disease-modifying agents for the prevention, treatment and restoration of neurodegenative disorders will have tremendous scientific and economic values.

PolyU has developed a series of dimers derived from tacrine, a drug currently used for treating Alzheimer’s disease. These dimers are multi-targeting drugs which can inhibit acetylcholinesterase and anti-neurotoxicity. When compared with the existing drugs, these novel multifunctional dimers have shown more promising anti-AD effects on models with AD in vitro and in vivo.

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here